Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_assertion type Assertion NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_head.
- NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_assertion description "[In both men and women, individuals with variant TS alleles were at reduced risk of having an advanced stage tumor (metastatic disease: OR = 0.35, 95% CI: 0.2-0.6 vs. wildtype TSER and 3'-UTR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_provenance.
- NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_assertion evidence source_evidence_literature NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_provenance.
- NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_assertion SIO_000772 17290389 NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_provenance.
- NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_assertion wasDerivedFrom befree-20140225 NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_provenance.
- NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_assertion wasGeneratedBy ECO_0000203 NP563778.RASxbO1csUJTwaH2DWRCFOX4pJ7PuN4RCHvGn_oRxKJt0130_provenance.